Chau, W K
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling. [electronic resource]
- Oncogene May 2013
- 2767-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1476-5594
Standard No.: 10.1038/onc.2012.290 doi
Subjects--Topical Terms: ATP Binding Cassette Transporter, Subfamily G, Member 2 ATP-Binding Cassette Transporters--metabolism Animals Antineoplastic Agents--pharmacology Benzamides--pharmacology Cell Hypoxia Cell Line, Tumor Cell Proliferation--drug effects Cell Survival--drug effects Cell Transformation, Neoplastic--genetics Cisplatin--pharmacology Drug Resistance, Neoplasm--genetics Female Gene Expression Regulation, Neoplastic Humans Imatinib Mesylate Mice Mice, Inbred BALB C Mice, Nude Neoplasm Proteins--metabolism Neoplastic Stem Cells--drug effects Ovarian Neoplasms--drug therapy Paclitaxel--pharmacology Piperazines--pharmacology Protein Kinase Inhibitors--pharmacology Proto-Oncogene Proteins c-kit--genetics Pyrimidines--pharmacology RNA Interference RNA, Small Interfering Tumor Microenvironment Wnt Proteins--metabolism Wnt Signaling Pathway--drug effects Xenograft Model Antitumor Assays beta Catenin--metabolism